These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 32631382)

  • 21. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
    Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
    Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
    Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
    Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
    Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
    Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
    Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
    [No Abstract]   [Full Text] [Related]  

  • 25. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.
    Ma L; Liu W; Xu A; Ji Q; Ma Y; Tai Y; Wang Y; Shen C; Liu Y; Wang T; Han J; Zhao C
    Cancer Sci; 2020 Jun; 111(6):2028-2040. PubMed ID: 32279388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.
    Li S; Wu L; Feng J; Li J; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Kong R; Chen K; Wang F; Xia Y; Lu J; Zhou Y; Dai W; Guo C
    Sci Rep; 2016 Jun; 6():28479. PubMed ID: 27349173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
    Hua S; Liu C; Liu L; Wu D
    Biochem Biophys Res Commun; 2018 Feb; 496(3):947-954. PubMed ID: 29360449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
    Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
    Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
    Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
    Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
    Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
    Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
    Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
    Shang RZ; Qu SB; Wang DS
    World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
    Fan P; Wang B; Meng Z; Zhao J; Jin X
    Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Pyruvate Kinase M2 Posttranslational Modification in the Occurrence and Development of Hepatocellular Carcinoma.
    Chunlian Z; Qi W; Rui Z
    Cell Biochem Funct; 2024 Sep; 42(7):e4125. PubMed ID: 39327771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PFKFB3/HIF-1α feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells.
    Long Q; Zou X; Song Y; Duan Z; Liu L
    Biochem Biophys Res Commun; 2019 Jun; 513(3):642-650. PubMed ID: 30981500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
    Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
    Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
    Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.
    Zhang LF; Lou JT; Lu MH; Gao C; Zhao S; Li B; Liang S; Li Y; Li D; Liu MF
    EMBO J; 2015 Nov; 34(21):2671-85. PubMed ID: 26346275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.